Employees: 12 (2023.0)Legal category: 5485Size: PMECreation date: 2006-04-01 (20 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CLAYE-SOUILLY (77410), Seine-et-Marne
PHARMACIE JAUGEON : revenue, balance sheet and financial ratios
PHARMACIE JAUGEON is a French company
founded 20 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CLAYE-SOUILLY (77410),
this company of category PME
shows in 2018 a revenue of 9.6 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE JAUGEON (SIREN 489677567)
Indicator
2024
2023
2018
2017
2016
Revenue
N/C
N/C
9 554 558 €
9 170 626 €
9 078 146 €
Net income
539 960 €
306 310 €
232 277 €
222 807 €
276 860 €
EBITDA
N/C
N/C
413 490 €
450 409 €
568 583 €
Net margin
N/C
N/C
2.4%
2.4%
3.0%
Revenue and income statement
In 2024, PHARMACIE JAUGEON generates positive net income of 540 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 277 k€ -> 540 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
539 960 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 37%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 63%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
37.03%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
63.065%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2023
2024
Debt ratio
185.571
173.992
127.965
58.421
37.03
Financial autonomy
30.876
32.228
37.916
56.403
63.065
Repayment capacity
16.461
19.818
17.396
None
None
Cash flow / Revenue
3.83%
3.166%
3.127%
None%
None%
Sector positioning
Debt ratio
37.032024
2018
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Good-15 pts over 3 years
In 2024, the debt ratio of PHARMACIE JAUGEON (37.03) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
63.06%2024
2018
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Good+18 pts over 3 years
In 2024, the financial autonomy of PHARMACIE JAUGEON (63.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
17.4 years2018
2018
Q1: 1.86 years
Med: 5.41 years
Q3: 9.79 years
Average
In 2018, the repayment capacity of PHARMACIE JAUGEON (17.40) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 198.36. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
198.356
Liquidity indicators evolution PHARMACIE JAUGEON
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2023
2024
Liquidity ratio
136.983
162.056
142.306
286.034
198.356
Interest coverage
23.348
26.237
22.617
None
None
Sector positioning
Liquidity ratio
198.362024
2018
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Good+17 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE JAUGEON (198.36) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
22.62x2018
2018
Q1: 1.93x
Med: 6.3x
Q3: 12.69x
Excellent
In 2018, the interest coverage of PHARMACIE JAUGEON (22.6x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE JAUGEON
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2023
2024
Operating WCR
926 062 €
1 000 057 €
992 432 €
0 €
0 €
Inventory turnover (days)
31
32
36
0
0
Customer payment term (days)
5
5
5
0
0
Supplier payment term (days)
44
46
48
0
0
Positioning of PHARMACIE JAUGEON in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE JAUGEON is estimated at
7 538 240 €
(range 5 249 511€ - 11 277 639€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
5249k€7538k€11277k€
7 538 240 €Range: 5 249 511€ - 11 277 639€
NAF 5 année 2024
Valuation method used
Net Income Multiple
539 960 €
×
14.0x
=7 538 241 €
Range: 5 249 512€ - 11 277 640€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE JAUGEON with other companies in the same sector:
Frequently asked questions about PHARMACIE JAUGEON
What is the revenue of PHARMACIE JAUGEON ?
The revenue of PHARMACIE JAUGEON in 2018 is 9.6 M€.
Is PHARMACIE JAUGEON profitable?
Yes, PHARMACIE JAUGEON generated a net profit of 540 k€ in 2024.
Where is the headquarters of PHARMACIE JAUGEON ?
The headquarters of PHARMACIE JAUGEON is located in CLAYE-SOUILLY (77410), in the department Seine-et-Marne.
Where to find the tax return of PHARMACIE JAUGEON ?
The tax return of PHARMACIE JAUGEON is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE JAUGEON operate?
PHARMACIE JAUGEON operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart